Evidence map›Paper›PMID 40010351›Full record

ArticleAmerican journal of human genetics2025

Variability in proliferative and migratory defects in Hirschsprung disease-associated RET pathogenic variants.

Lauren E Fries, Sree Dharma, Aravinda Chakravarti, Sumantra Chatterjee

Abstract read
In one paragraph

Article in American journal of human genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Joint disruption ofProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Lauren E FriesCenter for Human Genetics & Genomics, New York University Grossman School of Medicine, New York, NY 10016, USA.
Sree DharmaCenter for Human Genetics & Genomics, New York University Grossman School of Medicine, New York, NY 10016, USA.
Aravinda ChakravartiCenter for Human Genetics & Genomics, New York University Grossman School of Medicine, New York, NY 10016, USA; Department of Neuroscience and Physiology, New York University Grossman School of Medicine, New York, NY 10016, USA. Electronic address: aravinda.chakravarti@nyulangone.org.
Sumantra ChatterjeeCenter for Human Genetics & Genomics, New York University Grossman School of Medicine, New York, NY 10016, USA; Department of Neuroscience and Physiology, New York University Grossman School of Medicine, New York, NY 10016, USA. Electronic address: sumantra.chatterjee@nyulangone.org.

Funding

Genetic Analysis of Hirschsprung Disease - RenewalR01HD028088 · NICHD · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CHAKRAVARTI, ARAVINDA · 1991 to 2024
$6.2M
Genetic Analysis of Hirschsprung DiseaseR37HD028088 · NICHD · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CHAKRAVARTI, ARAVINDA · 2010 to 2019
$6.2M
Why do Down Syndrome patients have high risk of Hirschsprung disease?R01DK135089 · NIDDK · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ARAVINDA CHAKRAVARTI, Sumantra Chatterjee · 2022 to 2026
$4.2M
Computational identification of Hirschsprung disease susceptibility genesR03HD116004 · NICHD · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CHATTERJEE, SUMANTRA · 2024 to 2024
$339k
NICHD NIH HHS R01 HD028088NICHD NIH HHS R03 HD116004NICHD NIH HHS R37 HD028088NIDDK NIH HHS R01 DK135089
6 · The paper itself

Abstract

Hirschsprung disease (HSCR) exhibits extensive genetic heterogeneity, with 72% of cases involving pathogenic variants in 10 genes forming a gene regulatory network (GRN) essential for enteric nervous system (ENS) development. The receptor tyrosine kinase gene RET is the most significant contributor, implicated in 12%-50% of individuals depending on the phenotype. RET plays a critical role in ENS precursor proliferation and migration, and defects in these processes lead to HSCR. However, the functional impact of RET pathogenic variants and their mechanisms of disease remain poorly understood. To address this, we investigated proliferative and migratory phenotypes in a RET-dependent neural crest-derived cell line harboring one of five missense (c.166C>A [p.Leu56Met]; c.532G>C [p.Glu178Gln]; c.2372A>T [p.Tyr791Phe]; c.2765C>A [p.Ser922Tyr]; or c.2994T>A [p.Phe998Leu]) or three nonsense (c.612C>A, c.2308C>T, or c.2943C>G) heterozygous pathogenic RET variants. Using cDNA- and CRISPR-based prime reverse insertion mechanism engineering (PRIME) editing coupled with quantitative proliferation and migration assays, we observed significant losses in proliferation and migration in three missense (c.612C>A [p.Tyr204

Indexed as

Cell MovementCell ProliferationHirschsprung DiseaseProto-Oncogene Proteins c-retCell LineEnteric Nervous SystemHumansMutation, MissenseNeural CrestPhenotypeProto-Oncogene Proteins c-retRET protein, humancoding variantsfunctional validationgenome engineeringHirschsprung diseasemigration assayPRIME editingproliferation assayRET

Identifiers

PMID40010351
PMCPMC12081219

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.